PS: This inference is based on industry differentiation (only under hypothetical circumstances).
If a medical technology in a Chinese medicine industry is passed down through the family-style craftsman spirit, it is scarce and difficult to imitate (at least in the short term) compared with other enterprises in terms of customers, capabilities and resources (medical skills, medicines, etc.). ). To a certain extent, it has caused the differentiation of the exclusive field of the industry, set up entry barriers, and made it difficult for potential competitors to enter.
Due to the scarcity of production capacity and resources, it is difficult to find other alternative technologies for this medical technology in the industry. This medical technology not only increases the business risk of competitors in the industry, but also reduces the opportunistic cost of raw material suppliers and buyers, making it difficult to implement vertical integration (at least in the short term) through the scarcity of pharmacology and the differentiation strategy in the industry.